TrialClinical lymphoma, myeloma & leukemia2018

Improvement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

Jacqueline C Barrientos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.